Enavate Sciences GP
Latest statistics and disclosures from Enavate Sciences GP's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SION, IMNM, ZBIO, CMPX, BBOT, and represent 90.95% of Enavate Sciences GP's stock portfolio.
- Reduced shares in these 2 stocks: IMNM (-$25M), CAMP.
- Enavate Sciences GP was a net seller of stock by $-29M.
- Enavate Sciences GP has $352M in assets under management (AUM), dropping by -30.64%.
- Central Index Key (CIK): 0001953107
Tip: Access up to 7 years of quarterly data
Positions held by Enavate Sciences GP consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Enavate Sciences GP
Enavate Sciences GP holds 7 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Sionna Therapeutics (SION) | 28.3 | $99M | 2.5M | 40.09 |
|
|
| Immunome (IMNM) | 22.5 | $79M | -24% | 3.6M | 21.87 |
|
| Zenas Biopharma (ZBIO) | 21.8 | $77M | 3.9M | 19.55 |
|
|
| Compass Therapeutics (CMPX) | 11.7 | $41M | 7.8M | 5.29 |
|
|
| Bridgebio Oncology Therapeut Com New (BBOT) | 6.7 | $24M | 2.6M | 8.95 |
|
|
| Upstream Bio (UPB) | 6.3 | $22M | 2.5M | 9.00 |
|
|
| Camp4 Therapeutics Corp (CAMP) | 2.7 | $9.7M | -27% | 2.2M | 4.41 |
|
Past Filings by Enavate Sciences GP
SEC 13F filings are viewable for Enavate Sciences GP going back to 2025
- Enavate Sciences GP 2026 Q1 filed May 15, 2026
- Enavate Sciences GP 2025 Q4 filed Feb. 17, 2026
- Enavate Sciences GP 2025 Q3 filed Nov. 14, 2025
- Enavate Sciences GP 2025 Q2 filed Aug. 14, 2025
- Enavate Sciences GP 2025 Q1 filed May 15, 2025